News

April 18, 2019April 18, 2019

Heart’s Ventricular Mass on MRI May Predict Risk of Death in PAH, Study Says

News, PAH News

The heart’s ventricular mass may be an early prognostic biomarker for predicting the risk of heart failure and death in people with pulmonary arterial hypertension (PAH), a recent study suggests. ... Read more

April 17, 2019April 17, 2019

Team PHenomenal Hope Gears Up for 6th Annual 5K Fundraiser

News

As they have for the past five years, members of the pulmonary hypertension (PH) community are preparing to participate in PHenomenal Hope 5K, an event established to raise disease awareness and ... Read more

April 15, 2019April 15, 2019

PH Patients in UK Experience Diagnosis Delay, Heavy Disease Burden, Survey Says

News, PH News

Patients with pulmonary hypertension (PH) living in the U.K. experience delayed diagnosis, which has important implications for their financial and emotional status, according to a survey conducted by the ... Read more

April 12, 2019

10 Exercise Myths and Truths: Advice from a Respiratory Specialist

News

Myth 1: If you can’t run with the big dogs, stay on the porch. Truth: In the words of the late great Dr. Martin Luther King Jr., “if you ... Read more

April 12, 2019April 12, 2019

Mallinckrodt’s INOmax Approved in Australia for Adults with Perioperative PH and Heart Surgery

News, PH News

The health regulatory agency for Australia has approved Mallinckrodt Pharmaceuticals‘ INOmax (nitric oxide) gas for inhalation as a treatment for adult patients with perioperative pulmonary hypertension (PH) in combination with cardiovascular (heart) ... Read more

April 11, 2019April 11, 2019

United Therapeutics Ends Clinical Development of Esuberaprost as Add-on Therapy for PAH

News, PAH News

United Therapeutics announced it has ended its Phase 3 BEAT trial testing esuberaprost as an add-on therapy to its product Tyvaso (inhaled treprostinil) for clinically symptomatic patients with pulmonary arterial hypertension (PAH). According ... Read more

April 10, 2019

FDA Agrees to Change Study of Bellerophon’s INOpulse for PH-ILD Patients

News

The U.S. Food and Drug Administration (FDA) has agreed to change the ongoing Phase 2b study evaluating INOpulse in patients with pulmonary hypertension (PH) associated with interstitial lung disease (PH-ILD) into a Phase 2/3 clinical ... Read more

April 8, 2019April 18, 2019

Vasodilator Combo Can Treat PH-associated POEMS Syndrome, Report Says

News, PH News

Combined therapy with Revatio (sildenafil) and Opsumit (macitentan) was effective in a patient diagnosed with pulmonary hypertension (PH) associated with a rare blood disorder called polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and ... Read more

April 5, 2019April 5, 2019

LRP1 Protein Levels Linked to Blood Vessel Remodeling in PH, Study Suggests

News, PAH News, PH News

Increased levels of a protein called LRP1 may lead to blood vessel remodeling in pulmonary hypertension (PH) by causing changes in pulmonary artery cells that favor their proliferation, a ... Read more

April 4, 2019April 18, 2019

Systemic Hypertension a Predictor of PAH in Lupus Patients, Retrospective Study Finds

News, PAH News

Systemic hypertension is an independent predictor in rare cases of pulmonary arterial hypertension (PAH) associated with systemic lupus erythematosus (SLE), a retrospective large-cohort study in Taiwan shows. According to the ... Read more

Pin It on Pinterest